Advance in resistant biomarkers of chemotherapy to non-small cell lung cancer

Journal Title: 现代药物与临床 - Year 2011, Vol 26, Issue 6

Abstract

Non-small cell lung cancer (NSCLC) is highly occurred in China, which has become the major cancer influencing human health. Nowadays the standard treatment for NSCLC is chemotherapy, however, chemoresistance was more and more frequently found in many patients, which to result in bad prognosis.So, lots of research on chemoresistant biomarkers in NSCLC has been launched. These biomarkers refer to several types of chemotherapeutics which could guide the therapeutic schedule in clinical medicine selections. In this article we focus on analyzing several chemoresistant biomarkers which may play an important role in implementation of individualized treatment for NSCLC.

Authors and Affiliations

FU Gang, PAN Ming-jia, GONG Min, XU Wei-ren

Keywords

Related Articles

Preparation and release mechanism of Metlazone Sustained Release Tablets

Objective To prepare Metlazone Sustained Release Tablets, and study their release mechanisms. Methods The effects of many factors, including formulation and technique on the release behavior of Metlazone Sustained Releas...

Clinical efficacy analysis on leflunomide and Shenyitong Granule combination in treatment of mesangial proliferative glomerulonephritis

Objective To observe the clinical efficacy of leflunomide and Shenyitong Granule combination in treatment of mesangial proliferative glomerulonephritis. Methods Sixty-five patients were randomly divided into the leflunom...

Advance in resistant biomarkers of chemotherapy to non-small cell lung cancer

Non-small cell lung cancer (NSCLC) is highly occurred in China, which has become the major cancer influencing human health. Nowadays the standard treatment for NSCLC is chemotherapy, however, chemoresistance was more and...

Absorption characteristics of picroside Ⅱ in rat intestine[i] in situ[/i]

Objective To investigate the absorption kinetics of picroside Ⅱ at different intestine segments of rats. Methods The intestine in rats was cannulated for in situ recirculation. Picroside Ⅱ concentration in the flux was m...

Advances in studies on drug carrier poly lactic-co-glycolic acid in controlled release microspheres

Poly lactic-co-glycolic acid (PLGA) is a biodegradable polymer used to fabricate devices for drug delivery and tissue engineering scaffolds, and has been approved by the FDA in US. Its application in fabrication of devic...

Download PDF file
  • EP ID EP86084
  • DOI -
  • Views 152
  • Downloads 0

How To Cite

FU Gang, PAN Ming-jia, GONG Min, XU Wei-ren (2011). Advance in resistant biomarkers of chemotherapy to non-small cell lung cancer. 现代药物与临床, 26(6), 421-425. https://europub.co.uk/articles/-A-86084